Response to Selective RET Inhibition With LOXO-292 in a Patient With RET Fusion-Positive Lung Cancer With Leptomeningeal Metastases
暂无分享,去创建一个
A. Drilon | M. Kris | N. Rekhtman | D. Hyman | R. Young | S. Rothenberg | P. Cotzia | R. Guo | Jason C. Chang | D. Henry | Mark Schreyer